首页 > 最新文献

The Cardiothoracic Surgeon最新文献

英文 中文
Correction: Mechanical mitral valve endurance in children under 2 years 更正:两岁以下儿童的二尖瓣机械耐力
Pub Date : 2024-09-06 DOI: 10.1186/s43057-024-00137-x
Mohamed H. Mashali, Ahmed F. Elmahrouk, Zaheer Ahmad, Osama Abdulrahman, Anas Farag Galleon, Amjad Al-Kouatli, Ahmed A. Jamjoom, Riad Abou Zahr
<p><b>Correction: Cardiothorac Surg 32, 12 (2024)</b></p><p><b>https://doi.org/10.1186/s43057-024-00131-3</b></p><br/><p>Following publication of the original article [1], the authors found an error in the affiliation of the 7<sup>th</sup> author, Ahmed A. Jamjoom. He was mistakenly assign to Affiliation 3. The details are given below:</p><p><b>Incorrect affiliation:</b></p><p><sup>3</sup>Cardio-thoracic Surgery Department, Faculty of Medicine, Elgeish Street Medical Campus, Tanta University, Tanta 31527, Egypt.</p><p><b>Correct affiliation:</b></p><p><sup>4</sup>Cardiac Surgery Section, Department of Cardiovascular, King Faisal Specialist Hospital and Research Center, P.O. Box: 40,047, 21,499 Jeddah, Saudi Arabia.</p><p>This correction does not affect the overall result or conclusion of the article. The original article [1] has been corrected.</p><ol data-track-component="outbound reference" data-track-context="references section"><li data-counter="1."><p>Mashali MH, Elmahrouk AF, Ahmad Z et al (2024) Mechanical mitral valve endurance in children under 2 years. Cardiothorac Surg 32:12. https://doi.org/10.1186/s43057-024-00131-3</p><p>Article Google Scholar </p></li></ol><p>Download references<svg aria-hidden="true" focusable="false" height="16" role="img" width="16"><use xlink:href="#icon-eds-i-download-medium" xmlns:xlink="http://www.w3.org/1999/xlink"></use></svg></p><h3>Authors and Affiliations</h3><ol><li><p>Pediatric Cardiology Division, Department of Pediatrics, King Faisal Specialist Hospital and Research Center, P.O. Box: 40047, 21499, Jeddah, Saudi Arabia</p><p>Mohamed H. Mashali, Zaheer Ahmad, Amjad Al-Kouatli & Riad Abou Zahr</p></li><li><p>Pediatric Cardiology Division, Department of Pediatrics, Kasr Al Ainy School of Medicine, Cairo University, 99 El-Manial St, Cairo, 11451, Egypt</p><p>Mohamed H. Mashali</p></li><li><p>Cardio- Thoracic Surgery Department, Faculty of Medicine, Elgeish Street Medical Campus, Tanta University, Tanta, 31527, Egypt</p><p>Ahmed F. Elmahrouk</p></li><li><p>Cardiac Surgery Section, Department of Cardiovascular, King Faisal Specialist Hospital and Research Center, P.O. Box: 40047, 21499, Jeddah, Saudi Arabia</p><p>Ahmed F. Elmahrouk & Ahmed A. Jamjoom</p></li><li><p>Department of Cardiac Surgery, Madina Cardiac Center, Madina, Saudi Arabia</p><p>Osama Abdulrahman</p></li><li><p>Pediatric Critical Care Division, Department of Pediatrics, King Faisal Specialist Hospital and Research Center, P. O. Box 40047, 21499, Jeddah, Saudi Arabia</p><p>Anas Farag Galleon</p></li></ol><span>Authors</span><ol><li><span>Mohamed H. Mashali</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Ahmed F. Elmahrouk</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Zaheer Ahmad</span>View author publications<p>You can also search for this author in <spa
更正:Cardiothorac Surg 32, 12 (2024)https://doi.org/10.1186/s43057-024-00131-3Following 原文[1]发表后,作者发现第 7 位作者 Ahmed A. Jamjoom 的所属单位有误。他被错误地分配到了所属单位 3。详情如下:错误单位:3Cardio-thoracic Surgery Department, Faculty of Medicine, Elgeish Street Medical Campus, Tanta University, Tanta 31527, Egypt.正确单位:4Cardiac Surgery Section, Department of Cardiovascular, King Faisal Specialist Hospital and Research Center, P.O. Box:40,047,21,499 Jeddah,Saudi Arabia.此更正不影响文章的整体结果或结论。Mashali MH, Elmahrouk AF, Ahmad Z et al (2024) Mechanical mitral valve endurance in children under 2 years.Cardiothorac Surg 32:12. https://doi.org/10.1186/s43057-024-00131-3Article Google Scholar Download references作者和所属单位费萨尔国王专科医院和研究中心儿科部小儿心脏病科,P.O. Box:40047, 21499, Jeddah, Saudi ArabiaMohamed H. Mashali, Zaheer Ahmad, Amjad Al-Kouatli & Riad Abou ZahrPediatric Cardiology Division, Department of Pediatrics, Kasr Al Ainy School of Medicine, Cairo University, 99 El-Manial St, Cairo, 11451, EgyptMohamed H. MashaliCardio- Thoradio & Riad Abou Zahr.MashaliCardio- Thoracic Surgery Department, Faculty of Medicine, Elgeish Street Medical Campus, Tanta University, Tanta, 31527, EgyptAhmed F. ElmahroukCardiac Surgery Section, Department of Cardiovascular, King Faisal Specialist Hospital and Research Center, P.O. Box:Ahmed F. Elmahrouk & Ahmed A. JamjoomDepartment of Cardiac Surgery, Madina Cardiac Center, Madina, Saudi ArabiaOsama AbdulrahmanPediatric Critical Care Division, Department of Pediatrics, King Faisal Specialist Hospital and Research Center, P. O. Box 40047, 21499, Jeddah, Saudi ArabiaAhmed F. Elmahrouk & Ahmed A. JamjoomO. Box 40047, 21499, Jeddah, Saudi ArabiaAnas Farag Galleon作者Mohamed H. Mashali查看作者发表的文章您也可以在PubMed Google ScholarAhmed F. Elmahrouk中搜索该作者。ElmahroukView 作者发表作品您也可以在PubMed Google Scholar中搜索该作者Zaheer AhmadView 作者发表作品您也可以在PubMed Google Scholar中搜索该作者Osama AbdulrahmanView 作者发表作品您也可以在PubMed Google Scholar中搜索该作者Anas Farag GalleonView 作者发表作品您也可以在PubMed Google Scholar中搜索该作者Amjad Al-KouatliView 作者发表作品您也可以在PubMed Google Scholar中搜索该作者Ahmed A. Jamjoom查看作者发表作品JamjoomView author publications您还可以在PubMed Google Scholar中搜索该作者Riad Abou ZahrView author publications您还可以在PubMed Google Scholar中搜索该作者Corresponding authorCorrespondence to Ahmed F. Elmahrouk.Open Access本文采用知识共享署名 4.0 国际许可协议进行许可。0 国际许可协议,该协议允许以任何媒介或格式使用、共享、改编、分发和复制本文,但必须注明原作者和出处,提供知识共享许可协议的链接,并说明是否进行了修改。本文中的图片或其他第三方材料均包含在文章的知识共享许可协议中,除非在材料的署名栏中另有说明。如果材料未包含在文章的知识共享许可协议中,且您打算使用的材料不符合法律规定或超出许可使用范围,则您需要直接从版权所有者处获得许可。如需查看该许可的副本,请访问 http://creativecommons.org/licenses/by/4.0/.Reprints and permissionsCite this articleMashali, M.H., Elmahrouk, A.F., Ahmad, Z. et al. Correction:两岁以下儿童的二尖瓣机械耐力。Cardiothorac Surg 32, 18 (2024). https://doi.org/10.1186/s43057-024-00137-xDownload citationPublished: 06 September 2024DOI: https://doi.org/10.1186/s43057-024-00137-xShare this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this articl
{"title":"Correction: Mechanical mitral valve endurance in children under 2 years","authors":"Mohamed H. Mashali, Ahmed F. Elmahrouk, Zaheer Ahmad, Osama Abdulrahman, Anas Farag Galleon, Amjad Al-Kouatli, Ahmed A. Jamjoom, Riad Abou Zahr","doi":"10.1186/s43057-024-00137-x","DOIUrl":"https://doi.org/10.1186/s43057-024-00137-x","url":null,"abstract":"&lt;p&gt;&lt;b&gt;Correction: Cardiothorac Surg 32, 12 (2024)&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;https://doi.org/10.1186/s43057-024-00131-3&lt;/b&gt;&lt;/p&gt;&lt;br/&gt;&lt;p&gt;Following publication of the original article [1], the authors found an error in the affiliation of the 7&lt;sup&gt;th&lt;/sup&gt; author, Ahmed A. Jamjoom. He was mistakenly assign to Affiliation 3. The details are given below:&lt;/p&gt;&lt;p&gt;&lt;b&gt;Incorrect affiliation:&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;sup&gt;3&lt;/sup&gt;Cardio-thoracic Surgery Department, Faculty of Medicine, Elgeish Street Medical Campus, Tanta University, Tanta 31527, Egypt.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Correct affiliation:&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;sup&gt;4&lt;/sup&gt;Cardiac Surgery Section, Department of Cardiovascular, King Faisal Specialist Hospital and Research Center, P.O. Box: 40,047, 21,499 Jeddah, Saudi Arabia.&lt;/p&gt;&lt;p&gt;This correction does not affect the overall result or conclusion of the article. The original article [1] has been corrected.&lt;/p&gt;&lt;ol data-track-component=\"outbound reference\" data-track-context=\"references section\"&gt;&lt;li data-counter=\"1.\"&gt;&lt;p&gt;Mashali MH, Elmahrouk AF, Ahmad Z et al (2024) Mechanical mitral valve endurance in children under 2 years. Cardiothorac Surg 32:12. https://doi.org/10.1186/s43057-024-00131-3&lt;/p&gt;&lt;p&gt;Article Google Scholar &lt;/p&gt;&lt;/li&gt;&lt;/ol&gt;&lt;p&gt;Download references&lt;svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"&gt;&lt;use xlink:href=\"#icon-eds-i-download-medium\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/p&gt;&lt;h3&gt;Authors and Affiliations&lt;/h3&gt;&lt;ol&gt;&lt;li&gt;&lt;p&gt;Pediatric Cardiology Division, Department of Pediatrics, King Faisal Specialist Hospital and Research Center, P.O. Box: 40047, 21499, Jeddah, Saudi Arabia&lt;/p&gt;&lt;p&gt;Mohamed H. Mashali, Zaheer Ahmad, Amjad Al-Kouatli &amp; Riad Abou Zahr&lt;/p&gt;&lt;/li&gt;&lt;li&gt;&lt;p&gt;Pediatric Cardiology Division, Department of Pediatrics, Kasr Al Ainy School of Medicine, Cairo University, 99 El-Manial St, Cairo, 11451, Egypt&lt;/p&gt;&lt;p&gt;Mohamed H. Mashali&lt;/p&gt;&lt;/li&gt;&lt;li&gt;&lt;p&gt;Cardio- Thoracic Surgery Department, Faculty of Medicine, Elgeish Street Medical Campus, Tanta University, Tanta, 31527, Egypt&lt;/p&gt;&lt;p&gt;Ahmed F. Elmahrouk&lt;/p&gt;&lt;/li&gt;&lt;li&gt;&lt;p&gt;Cardiac Surgery Section, Department of Cardiovascular, King Faisal Specialist Hospital and Research Center, P.O. Box: 40047, 21499, Jeddah, Saudi Arabia&lt;/p&gt;&lt;p&gt;Ahmed F. Elmahrouk &amp; Ahmed A. Jamjoom&lt;/p&gt;&lt;/li&gt;&lt;li&gt;&lt;p&gt;Department of Cardiac Surgery, Madina Cardiac Center, Madina, Saudi Arabia&lt;/p&gt;&lt;p&gt;Osama Abdulrahman&lt;/p&gt;&lt;/li&gt;&lt;li&gt;&lt;p&gt;Pediatric Critical Care Division, Department of Pediatrics, King Faisal Specialist Hospital and Research Center, P. O. Box 40047, 21499, Jeddah, Saudi Arabia&lt;/p&gt;&lt;p&gt;Anas Farag Galleon&lt;/p&gt;&lt;/li&gt;&lt;/ol&gt;&lt;span&gt;Authors&lt;/span&gt;&lt;ol&gt;&lt;li&gt;&lt;span&gt;Mohamed H. Mashali&lt;/span&gt;View author publications&lt;p&gt;You can also search for this author in &lt;span&gt;PubMed&lt;span&gt; &lt;/span&gt;Google Scholar&lt;/span&gt;&lt;/p&gt;&lt;/li&gt;&lt;li&gt;&lt;span&gt;Ahmed F. Elmahrouk&lt;/span&gt;View author publications&lt;p&gt;You can also search for this author in &lt;span&gt;PubMed&lt;span&gt; &lt;/span&gt;Google Scholar&lt;/span&gt;&lt;/p&gt;&lt;/li&gt;&lt;li&gt;&lt;span&gt;Zaheer Ahmad&lt;/span&gt;View author publications&lt;p&gt;You can also search for this author in &lt;spa","PeriodicalId":501458,"journal":{"name":"The Cardiothoracic Surgeon","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142207020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel approach, AngioVac use in right-sided infective endocarditis: a scoping review 一种新方法:在右侧感染性心内膜炎中使用 AngioVac:范围综述
Pub Date : 2024-08-24 DOI: 10.1186/s43057-024-00136-y
Fahad M. Alshair, Amal S. Alsulami, Abdullah H. Baghaffar, Mazin A. Fatani
Infective endocarditis is an infection of microbial origin affecting the endocardial layer of the heart, mostly impacting the heart valves. Right-sided infective endocarditis mainly affects the tricuspid valve. In some cases where surgical management is indicated the patients might not be good candidates for surgery. The AngioVac drainage cannula (AngioDynamics, Latham, NY, USA) is a novel device used in debulking and suction of intravascular material. It has been reported in the literature as a novel treatment for patients with right-sided tricuspid valve endocarditis vegetations, where their size is reduced and the efficacy of antibiotics in clearing the bloodstream infection is enhanced. We conducted a thorough literature review to assess the uses of the AngioVac drainage cannula in the management of right-sided infective endocarditis vegetations and lesions. We collected all reported cases where the system was used for the management of right-sided infective endocarditis and performed an encompassing review of the literature. In the review, we found 65 cases reported using the AngioVac drainage cannula for the removal of right-sided infective endocarditis vegetations. Majority of the cases were successful with no complications (87.6%); 7 (10.7%) cases were successful but there were complications: 2 reported mortalities, 1 patient had worsening TR during follow-up, 3 had recurrence of the vegetation, and 1 patient remained bacteremic. There was only 1 reported failure. Four (6.1%) patients required postprocedural valvular surgery with 3 repairs and a single valve replacement. The AngioVac system is a possible bailout option for surgeons managing patients with right-sided infective endocarditis vegetations who are not ideal candidates for surgery. With increased reports on its use, it could be effective at reducing the microbiological burden with minimal complications.
感染性心内膜炎是一种影响心脏心内膜层的微生物感染,主要影响心脏瓣膜。右侧感染性心内膜炎主要影响三尖瓣。在某些需要手术治疗的病例中,患者可能并不适合手术。AngioVac 引流套管(AngioDynamics,Latham,NY,USA)是一种用于清除和抽吸血管内物质的新型装置。据文献报道,它是治疗右侧三尖瓣心内膜炎植物瘤患者的一种新方法,可缩小植物瘤的大小,提高抗生素清除血流感染的疗效。我们进行了全面的文献综述,以评估 AngioVac 引流套管在治疗右侧感染性心内膜炎植被和病变中的应用。我们收集了所有使用该系统治疗右侧感染性心内膜炎的报告病例,并对文献进行了全面回顾。在综述中,我们发现了 65 个使用 AngioVac 引流套管切除右侧感染性心内膜炎植被的病例。大多数病例成功,无并发症(87.6%);7 例(10.7%)成功,但有并发症:2例报告死亡,1例患者在随访期间TR恶化,3例植被复发,1例患者仍为菌血症。只有 1 例报告失败。四名患者(6.1%)需要在手术后进行瓣膜手术,其中三人进行了修补,一人进行了瓣膜置换。对于管理右侧感染性心内膜炎植物瓣的外科医生来说,AngioVac 系统是一种可能的救助选择,因为这些患者并不是手术的理想人选。随着使用报告的增加,该系统可有效减少微生物负担,并将并发症降至最低。
{"title":"A novel approach, AngioVac use in right-sided infective endocarditis: a scoping review","authors":"Fahad M. Alshair, Amal S. Alsulami, Abdullah H. Baghaffar, Mazin A. Fatani","doi":"10.1186/s43057-024-00136-y","DOIUrl":"https://doi.org/10.1186/s43057-024-00136-y","url":null,"abstract":"Infective endocarditis is an infection of microbial origin affecting the endocardial layer of the heart, mostly impacting the heart valves. Right-sided infective endocarditis mainly affects the tricuspid valve. In some cases where surgical management is indicated the patients might not be good candidates for surgery. The AngioVac drainage cannula (AngioDynamics, Latham, NY, USA) is a novel device used in debulking and suction of intravascular material. It has been reported in the literature as a novel treatment for patients with right-sided tricuspid valve endocarditis vegetations, where their size is reduced and the efficacy of antibiotics in clearing the bloodstream infection is enhanced. We conducted a thorough literature review to assess the uses of the AngioVac drainage cannula in the management of right-sided infective endocarditis vegetations and lesions. We collected all reported cases where the system was used for the management of right-sided infective endocarditis and performed an encompassing review of the literature. In the review, we found 65 cases reported using the AngioVac drainage cannula for the removal of right-sided infective endocarditis vegetations. Majority of the cases were successful with no complications (87.6%); 7 (10.7%) cases were successful but there were complications: 2 reported mortalities, 1 patient had worsening TR during follow-up, 3 had recurrence of the vegetation, and 1 patient remained bacteremic. There was only 1 reported failure. Four (6.1%) patients required postprocedural valvular surgery with 3 repairs and a single valve replacement. The AngioVac system is a possible bailout option for surgeons managing patients with right-sided infective endocarditis vegetations who are not ideal candidates for surgery. With increased reports on its use, it could be effective at reducing the microbiological burden with minimal complications.","PeriodicalId":501458,"journal":{"name":"The Cardiothoracic Surgeon","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142207021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sixteen-year outcomes of patients undergoing minimally invasive direct coronary artery bypass surgery: a single-center experience 接受微创直接冠状动脉搭桥手术患者的 16 年疗效:单中心经验
Pub Date : 2024-08-02 DOI: 10.1186/s43057-024-00135-z
Oluwanifemi Akintoye, Aabha Divya, Shakil Farid, Samer Nashef, Ravi De Silva
Minimally invasive direct coronary artery bypass (MIDCAB) grafting is a safe technique for revascularization of the left anterior descending artery. The objective of this study was to evaluate the long-term outcomes of patients who underwent MIDCAB surgery in our institution. This was a retrospective, observational outcome study of retrospectively collected data. Data was collected using community, electronic, and paper medical records as well as telephone follow-up conversations with patients who underwent MIDCAB between December 1996 and June 2021. The primary outcome measure was mortality. Secondary outcomes included revascularization, myocardial infarction, and wound infection. Survival analysis was performed using the Kaplan–Meier method. A total of 215 patients were identified in the study period undergoing MIDCAB at our center. The median age was 77 years, and the cohort consisted of 180 (83.3%) of male patients. The median follow-up period was 16 years (12.1–17.7). At follow-up, freedom from repeat left anterior descending revascularization and from other vessels, revascularization was 96.7% and 89.1% respectively. Survival rates were 99.5%, 81.0%, and 45.2% survival at 1 year, 10 years, and 25 years respectively. Univariate analysis showed age (p < 0.01, Hazard ratio 1.08 confidence interval 1.05–1.11) and left ventricular function (p < 0.01, hazard ratio 2.40, confidence interval 1.66–3.45) as factors associated with mortality. Our single-center experience of MIDCAB demonstrated excellent long-term freedom from revascularization and other complications. Although limited by the retrospective nature, the study shows MIDCAB to be a safe procedure for definitive revascularization of the left anterior descending coronary artery.
微创直接冠状动脉搭桥术(MIDCAB)是一种安全的左前降支动脉再血管化技术。本研究旨在评估在我院接受 MIDCAB 手术的患者的长期疗效。这是一项对回顾性数据进行的回顾性观察结果研究。数据通过社区、电子和纸质病历以及与 1996 年 12 月至 2021 年 6 月间接受 MIDCAB 手术患者的电话随访交谈收集。主要结果是死亡率。次要结果包括血管再通、心肌梗死和伤口感染。采用 Kaplan-Meier 法进行生存分析。研究期间,共有 215 名患者在本中心接受了 MIDCAB 手术。中位年龄为 77 岁,其中男性患者 180 名(83.3%)。中位随访时间为 16 年(12.1-17.7)。随访期间,不再接受左前降支血管再通手术和不再接受其他血管再通手术的比例分别为96.7%和89.1%。1年、10年和25年的存活率分别为99.5%、81.0%和45.2%。单变量分析显示,年龄(P < 0.01,危险比 1.08,置信区间 1.05-1.11)和左心室功能(P < 0.01,危险比 2.40,置信区间 1.66-3.45)是死亡率的相关因素。我们单中心的 MIDCAB 经验表明,患者长期无血运重建和其他并发症。虽然这项研究具有回顾性的局限性,但它表明 MIDCAB 是一种安全的冠状动脉左前降支明确再通术。
{"title":"Sixteen-year outcomes of patients undergoing minimally invasive direct coronary artery bypass surgery: a single-center experience","authors":"Oluwanifemi Akintoye, Aabha Divya, Shakil Farid, Samer Nashef, Ravi De Silva","doi":"10.1186/s43057-024-00135-z","DOIUrl":"https://doi.org/10.1186/s43057-024-00135-z","url":null,"abstract":"Minimally invasive direct coronary artery bypass (MIDCAB) grafting is a safe technique for revascularization of the left anterior descending artery. The objective of this study was to evaluate the long-term outcomes of patients who underwent MIDCAB surgery in our institution. This was a retrospective, observational outcome study of retrospectively collected data. Data was collected using community, electronic, and paper medical records as well as telephone follow-up conversations with patients who underwent MIDCAB between December 1996 and June 2021. The primary outcome measure was mortality. Secondary outcomes included revascularization, myocardial infarction, and wound infection. Survival analysis was performed using the Kaplan–Meier method. A total of 215 patients were identified in the study period undergoing MIDCAB at our center. The median age was 77 years, and the cohort consisted of 180 (83.3%) of male patients. The median follow-up period was 16 years (12.1–17.7). At follow-up, freedom from repeat left anterior descending revascularization and from other vessels, revascularization was 96.7% and 89.1% respectively. Survival rates were 99.5%, 81.0%, and 45.2% survival at 1 year, 10 years, and 25 years respectively. Univariate analysis showed age (p < 0.01, Hazard ratio 1.08 confidence interval 1.05–1.11) and left ventricular function (p < 0.01, hazard ratio 2.40, confidence interval 1.66–3.45) as factors associated with mortality. Our single-center experience of MIDCAB demonstrated excellent long-term freedom from revascularization and other complications. Although limited by the retrospective nature, the study shows MIDCAB to be a safe procedure for definitive revascularization of the left anterior descending coronary artery.","PeriodicalId":501458,"journal":{"name":"The Cardiothoracic Surgeon","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141882528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The current state of minimally invasive cardiac surgery in Africa: a systematic review and meta-analysis 非洲微创心脏手术的现状:系统回顾和荟萃分析
Pub Date : 2024-08-02 DOI: 10.1186/s43057-024-00134-0
Oluwanifemi O. Akintoye, Bukola G. Adu, Michael J. Otorkpa, Oluwatobi O. Olayode, Samuel Fodop, Peace O. Alemede, Ruth K. Enyong, Feziechi C. Anele, Benjamin I. Omoregbee
Globally, the utilisation of minimally invasive techniques has become increasingly prevalent. While traditional open-heart procedures still dominate the landscape, a significant portion of cardiac surgeries are now performed minimally invasively. The aim of this study is to provide an insightful overview of the current state of minimally invasive cardiac surgery in Africa. A comprehensive database search was performed on PubMed, African Journal Online, Google Scholar, and Scopus to identify published data reporting on outcomes of minimally invasive cardiac surgery in Africa, from inception till June 2024. We used the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines to undergo this study. The primary outcomes of interest were in-hospital mortality and overall mortality. Data were pooled together and analysed using a random effect model for meta-analysis with R software. Out of a total of 2309 articles identified, only fourteen papers met our inclusion criteria following deduplication and screening. The four countries with published research include Egypt, South Africa, Tanzania, and Morocco, with a total sample size of 1357 patients. The meta-analysis of the reported outcomes produced a pooled in-hospital mortality prevalence of 1.18%, while the pooled overall mortality prevalence was 2.23%. There was no statistically significant difference in outcomes between the mini sternotomy and the full sternotomy group. The pooled outcomes of minimally invasive cardiac surgery in Africa are comparable to those in other regions. However, there are several socio-economic factors limiting its widespread practice in Africa.
在全球范围内,微创技术的应用越来越普遍。虽然传统的开胸手术仍占主导地位,但现在有很大一部分心脏手术是以微创方式进行的。本研究旨在对非洲微创心脏手术的现状进行深入概述。我们在PubMed、African Journal Online、Google Scholar和Scopus上进行了全面的数据库搜索,以确定从开始到2024年6月有关非洲微创心脏手术结果报告的已发表数据。我们采用《系统综述和荟萃分析首选报告项目》指南来开展这项研究。我们关注的主要结果是院内死亡率和总死亡率。我们采用随机效应模型对数据进行汇总,并使用 R 软件进行元分析。在已确定的 2309 篇文章中,经过重复筛选,只有 14 篇符合我们的纳入标准。已发表研究论文的四个国家包括埃及、南非、坦桑尼亚和摩洛哥,总样本量为 1357 名患者。通过对报告结果进行荟萃分析,汇总的院内死亡率为 1.18%,而汇总的总体死亡率为 2.23%。微型胸骨切开术组和全胸骨切开术组的结果在统计学上没有明显差异。非洲微创心脏手术的汇总结果与其他地区相当。然而,一些社会经济因素限制了微创心脏手术在非洲的广泛开展。
{"title":"The current state of minimally invasive cardiac surgery in Africa: a systematic review and meta-analysis","authors":"Oluwanifemi O. Akintoye, Bukola G. Adu, Michael J. Otorkpa, Oluwatobi O. Olayode, Samuel Fodop, Peace O. Alemede, Ruth K. Enyong, Feziechi C. Anele, Benjamin I. Omoregbee","doi":"10.1186/s43057-024-00134-0","DOIUrl":"https://doi.org/10.1186/s43057-024-00134-0","url":null,"abstract":"Globally, the utilisation of minimally invasive techniques has become increasingly prevalent. While traditional open-heart procedures still dominate the landscape, a significant portion of cardiac surgeries are now performed minimally invasively. The aim of this study is to provide an insightful overview of the current state of minimally invasive cardiac surgery in Africa. A comprehensive database search was performed on PubMed, African Journal Online, Google Scholar, and Scopus to identify published data reporting on outcomes of minimally invasive cardiac surgery in Africa, from inception till June 2024. We used the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines to undergo this study. The primary outcomes of interest were in-hospital mortality and overall mortality. Data were pooled together and analysed using a random effect model for meta-analysis with R software. Out of a total of 2309 articles identified, only fourteen papers met our inclusion criteria following deduplication and screening. The four countries with published research include Egypt, South Africa, Tanzania, and Morocco, with a total sample size of 1357 patients. The meta-analysis of the reported outcomes produced a pooled in-hospital mortality prevalence of 1.18%, while the pooled overall mortality prevalence was 2.23%. There was no statistically significant difference in outcomes between the mini sternotomy and the full sternotomy group. The pooled outcomes of minimally invasive cardiac surgery in Africa are comparable to those in other regions. However, there are several socio-economic factors limiting its widespread practice in Africa.","PeriodicalId":501458,"journal":{"name":"The Cardiothoracic Surgeon","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141882461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subclinical venous thromboembolism after pulmonary resection for lung cancer: an observational study 肺癌肺切除术后的亚临床静脉血栓栓塞症:一项观察性研究
Pub Date : 2024-07-27 DOI: 10.1186/s43057-024-00133-1
Hany Hasan Elsayed, Ahmed Anwar El-Nori, Ahmed Mostafa, Mohamed Tarek Elsayegh, Mohamed Magdy Barien
Subclinical venous thromboembolism is a hidden pathology which may present with catastrophic consequences if not diagnosed at an early stage. This study was undertaken to estimate the occurrence and associated risk factors of subclinical deep vein thrombosis after lung resection for lung cancer patients. A prospective observational cohort study was performed in a tertiary cardiothoracic surgery center. One hundred fifty patients who underwent different types of lung resection for lung cancer were enrolled. Caprini’s risk score was assessed in all patients. All patients received prophylactic stockings and anticoagulants. On the 5th postoperative day, a duplex venous ultrasound of bilateral lower limbs was performed on every asymptomatic patient. Out of 150 patients enrolled in the study, 147 patients completed the study. Four patients (2.72%) developed subclinical deep vein thrombosis. The patients were divided into 2 groups: group 1 (n = 143) post-lung resection and no DVT and group 2 (n = 4) with post-lung resection subclinical DVT. No patient developed postoperative clinical DVT. The incidence was found to be highest in the group of individuals who had a longer stay in the ICU (odds ratio 37.9) (p = 0.04). Among the various pathologies, the incidence was higher in patients who received preoperative chemotherapy (odds ratio 21.9) (p = 0.001). One patient in the subclinical DVT group (25%) died, while no mortality was observed in the no DVT group. The incidence of subclinical deep vein thrombosis is low in the postoperative period among patients undergoing lung resection for lung cancer if appropriate prophylactic measures are applied. However, patients receiving preoperative chemotherapy and those with longer periods of immobilization are at a higher risk of developing postoperative DVT despite anticoagulant prophylaxis. Due to the sample size and design limitations, the mentioned risk factors could be associated with DVT not a cause of DVT. It might be justified to screen these high-risk groups to detect subclinical DVT to allow for post-discharge prophylaxis.
亚临床静脉血栓栓塞症是一种隐匿性病症,如果不及早诊断,可能会造成灾难性后果。本研究旨在估算肺癌患者肺切除术后亚临床深静脉血栓形成的发生率和相关风险因素。一项前瞻性观察性队列研究在一家三级心胸外科中心进行。150 名患者因肺癌接受了不同类型的肺切除术。对所有患者进行了卡普里尼风险评分。所有患者均接受了预防性长袜和抗凝剂治疗。术后第 5 天,对每位无症状的患者进行双侧下肢静脉超声检查。在 150 名参与研究的患者中,有 147 名患者完成了研究。4名患者(2.72%)出现了亚临床深静脉血栓。患者被分为两组:第一组(143 人)肺切除术后未出现深静脉血栓;第二组(4 人)肺切除术后出现亚临床深静脉血栓。没有患者在术后出现临床深静脉血栓。在重症监护室住院时间较长的一组患者中,深静脉血栓发生率最高(几率比为 37.9)(P = 0.04)。在各种病理类型中,术前接受化疗的患者发病率较高(几率比 21.9)(P = 0.001)。亚临床深静脉血栓组中有一名患者(25%)死亡,而无深静脉血栓组未观察到死亡病例。如果采取适当的预防措施,肺癌肺切除术患者术后亚临床深静脉血栓形成的发生率很低。然而,术前接受化疗和固定时间较长的患者尽管使用了抗凝剂预防措施,但术后发生深静脉血栓的风险较高。由于样本量和设计的限制,上述风险因素可能与深静脉血栓相关,而非深静脉血栓的原因。或许有理由对这些高危人群进行筛查,以发现亚临床深静脉血栓,从而在出院后采取预防措施。
{"title":"Subclinical venous thromboembolism after pulmonary resection for lung cancer: an observational study","authors":"Hany Hasan Elsayed, Ahmed Anwar El-Nori, Ahmed Mostafa, Mohamed Tarek Elsayegh, Mohamed Magdy Barien","doi":"10.1186/s43057-024-00133-1","DOIUrl":"https://doi.org/10.1186/s43057-024-00133-1","url":null,"abstract":"Subclinical venous thromboembolism is a hidden pathology which may present with catastrophic consequences if not diagnosed at an early stage. This study was undertaken to estimate the occurrence and associated risk factors of subclinical deep vein thrombosis after lung resection for lung cancer patients. A prospective observational cohort study was performed in a tertiary cardiothoracic surgery center. One hundred fifty patients who underwent different types of lung resection for lung cancer were enrolled. Caprini’s risk score was assessed in all patients. All patients received prophylactic stockings and anticoagulants. On the 5th postoperative day, a duplex venous ultrasound of bilateral lower limbs was performed on every asymptomatic patient. Out of 150 patients enrolled in the study, 147 patients completed the study. Four patients (2.72%) developed subclinical deep vein thrombosis. The patients were divided into 2 groups: group 1 (n = 143) post-lung resection and no DVT and group 2 (n = 4) with post-lung resection subclinical DVT. No patient developed postoperative clinical DVT. The incidence was found to be highest in the group of individuals who had a longer stay in the ICU (odds ratio 37.9) (p = 0.04). Among the various pathologies, the incidence was higher in patients who received preoperative chemotherapy (odds ratio 21.9) (p = 0.001). One patient in the subclinical DVT group (25%) died, while no mortality was observed in the no DVT group. The incidence of subclinical deep vein thrombosis is low in the postoperative period among patients undergoing lung resection for lung cancer if appropriate prophylactic measures are applied. However, patients receiving preoperative chemotherapy and those with longer periods of immobilization are at a higher risk of developing postoperative DVT despite anticoagulant prophylaxis. Due to the sample size and design limitations, the mentioned risk factors could be associated with DVT not a cause of DVT. It might be justified to screen these high-risk groups to detect subclinical DVT to allow for post-discharge prophylaxis.","PeriodicalId":501458,"journal":{"name":"The Cardiothoracic Surgeon","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141774714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bi-valve braces for treatment of pectus carinatum in teenagers: impact on patients quality of life 治疗青少年鸡胸的双瓣支架:对患者生活质量的影响
Pub Date : 2024-07-17 DOI: 10.1186/s43057-024-00132-2
Marion Mauduit, Anaëlle Chermat, Dorian Rojas, Simon Rouzé, Bertrand Delatour, Jean-Philippe Verhoye
Pectus carinatum may be a major issue for adolescent patients, as chest-wall malformations can have a negative impact on body image and induce self-esteem disorders. Bracing has become the first line treatment for adolescent patients whose anterior chest wall is still flexible. The main obstacle is the tolerability of the bracing device along with the patient’s compliance to the device. The aim of this study was to examine the quality of life of adolescent patients treated with bracing to correct pectus carinatum in our institution. From November 2021 to July 2023, 28 patients with pectus carinatum were treated with bracing therapy in our chest wall deformities unit. We used a bivalve brace, manufactured with computer-aided design. All patients were asked to answer a multiple-choice questionnaire designed to assess how bracing therapy impacts their daily life, treatment compliance, and overall satisfaction. Patients who wore the brace for at least 3 months, and at least 5 days per week and 10 h per day, are defined as compliant with the bracing protocol. The mean age of the patients was 14 ± 1.36 years. Patients wore the brace for an average of 10.1 ± 6.9 months in the compliance group (n = 18), and 2.2 ± 2.5 months in the non-compliance group (n = 10). Our results show that compliant patients are fairly satisfied of the comfort of the brace, with a limited impact of the device on their daily activities and social life. However, non-compliant patients report the following dissatisfactions regarding the brace: higher pain scores, difficulty in breathing, and issues sleeping with the brace. The compliant patients noted a significant improvement in the appearance of their chest, and were satisfied with the appearance of their chest. The non-compliant patients did not notice any changes. Compliant patients treated with a bi-valve brace for pectus carinatum seem to have a good quality of life with a limited impact on their daily life and social activities. The bi-valve brace also seems to be an effective therapy in compliant patients.
由于胸壁畸形会对身体形象产生负面影响,并诱发自尊障碍,因此,对于青少年患者来说,心胸畸形可能是一个重大问题。支架已成为前胸壁仍有弹性的青少年患者的一线治疗方法。其主要障碍在于支撑装置的耐受性以及患者对装置的依从性。本研究旨在考察本院接受支架矫正胸廓治疗的青少年患者的生活质量。自 2021 年 11 月至 2023 年 7 月,我院胸壁畸形科共对 28 名鸡胸患者进行了支撑治疗。我们使用的是计算机辅助设计制造的双瓣支架。我们要求所有患者回答一份多选题问卷,旨在评估支撑疗法对他们日常生活的影响、治疗依从性和总体满意度。佩戴支具至少 3 个月、每周至少 5 天、每天至少 10 小时的患者被定义为符合支具治疗方案。患者的平均年龄为 14±1.36 岁。符合要求组(18 人)患者佩戴支具的平均时间为(10.1 ± 6.9)个月,不符合要求组(10 人)患者佩戴支具的平均时间为(2.2 ± 2.5)个月。我们的结果表明,符合要求的患者对支具的舒适度相当满意,支具对其日常活动和社交生活的影响有限。然而,非达标患者对支架有以下不满意之处:疼痛评分较高、呼吸困难以及佩戴支架睡觉时出现问题。符合要求的患者注意到胸部外观有了明显改善,并对胸部外观表示满意。未遵医嘱的患者则没有发现任何变化。使用双瓣支架治疗贲门失弛缓症的达标患者似乎生活质量很高,对日常生活和社交活动的影响有限。双瓣膜支架对符合要求的患者似乎也是一种有效的治疗方法。
{"title":"Bi-valve braces for treatment of pectus carinatum in teenagers: impact on patients quality of life","authors":"Marion Mauduit, Anaëlle Chermat, Dorian Rojas, Simon Rouzé, Bertrand Delatour, Jean-Philippe Verhoye","doi":"10.1186/s43057-024-00132-2","DOIUrl":"https://doi.org/10.1186/s43057-024-00132-2","url":null,"abstract":"Pectus carinatum may be a major issue for adolescent patients, as chest-wall malformations can have a negative impact on body image and induce self-esteem disorders. Bracing has become the first line treatment for adolescent patients whose anterior chest wall is still flexible. The main obstacle is the tolerability of the bracing device along with the patient’s compliance to the device. The aim of this study was to examine the quality of life of adolescent patients treated with bracing to correct pectus carinatum in our institution. From November 2021 to July 2023, 28 patients with pectus carinatum were treated with bracing therapy in our chest wall deformities unit. We used a bivalve brace, manufactured with computer-aided design. All patients were asked to answer a multiple-choice questionnaire designed to assess how bracing therapy impacts their daily life, treatment compliance, and overall satisfaction. Patients who wore the brace for at least 3 months, and at least 5 days per week and 10 h per day, are defined as compliant with the bracing protocol. The mean age of the patients was 14 ± 1.36 years. Patients wore the brace for an average of 10.1 ± 6.9 months in the compliance group (n = 18), and 2.2 ± 2.5 months in the non-compliance group (n = 10). Our results show that compliant patients are fairly satisfied of the comfort of the brace, with a limited impact of the device on their daily activities and social life. However, non-compliant patients report the following dissatisfactions regarding the brace: higher pain scores, difficulty in breathing, and issues sleeping with the brace. The compliant patients noted a significant improvement in the appearance of their chest, and were satisfied with the appearance of their chest. The non-compliant patients did not notice any changes. Compliant patients treated with a bi-valve brace for pectus carinatum seem to have a good quality of life with a limited impact on their daily life and social activities. The bi-valve brace also seems to be an effective therapy in compliant patients.","PeriodicalId":501458,"journal":{"name":"The Cardiothoracic Surgeon","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141717572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanical mitral valve endurance in children under 2 years 两岁以下儿童的二尖瓣机械耐力
Pub Date : 2024-07-03 DOI: 10.1186/s43057-024-00131-3
Mohamed H. Mashali, Ahmed F. Elmahrouk, Zaheer Ahmad, Osama Abdulrahman, Anas Farag Galleon, Amjad Al-Kouatli, Ahmed A. Jamjoom, Riad Abou Zahr
The management of mitral valve disease in young children is challenging. Mechanical mitral valves could provide long-term durability; however, the need for anticoagulation increases the risk profile of mechanical valves. We report our experience in mechanical mitral valve replacement (MVR) in children under 2 years of age and evaluate factors affecting the outcomes. The study included all patients younger than 2 years who underwent mechanical MVR between 2000 and 2023. The study outcomes were mitral valve reoperation, bleeding, valve-related thrombosis, and survival. Twenty-three patients were included, with a mean age of 10.2 ± 5.9 months. The mitral valve sizes ranged from 16 to 25 mm, and 6 (26%) were placed in the supra-annular position. Complete heart block occurred in seven patients (30%), and operative mortality occurred in three patients (13%). Postoperative warfarin was used in 17 patients (74%). After discharge, bleeding occurred in five patients (22%), four were managed conservatively, and one had intracranial hemorrhage treated with craniotomy. Nine patients (39%) had valve-related thrombosis; two underwent reoperation, while seven were treated with alteplase in 26 patients. Valve-related thrombosis was more common in patients with supra-annular valves (p < 0.001) and in those who were not on warfarin (p < 0.001). A total of seven patients (30%) underwent redo MVR, and redo was more common in young patients (p = 0.029) and in patients with supra-annular valves (p < 0.001). Survival of the whole cohort was 73% at 5 years. Among the annular position group, 5-year survival was 88%, while among the supra-annular position group, survival was 50% after 3 months and 25% after 14 months (p = 0.009). Mechanical MVR in children younger than 2 years is associated with high complication rates, including thrombosis and bleeding. The supra-annular valve position appears to be a risk factor for thrombosis and reoperation. Anticoagulation with warfarin remains challenging. However, further studies evaluating alternative options are needed.
幼儿二尖瓣疾病的治疗具有挑战性。二尖瓣机械瓣膜可以提供长期的耐久性;然而,抗凝的需要增加了机械瓣膜的风险。我们报告了 2 岁以下儿童机械二尖瓣置换术(MVR)的经验,并评估了影响疗效的因素。研究对象包括 2000 年至 2023 年期间接受机械二尖瓣置换术的所有 2 岁以下患者。研究结果包括二尖瓣再手术、出血、瓣膜相关血栓形成和存活率。共纳入 23 名患者,平均年龄为(10.2±5.9)个月。二尖瓣大小从16毫米到25毫米不等,6例(26%)被置于环上位置。7名患者(30%)出现完全性心脏传导阻滞,3名患者(13%)出现手术死亡率。17 名患者(74%)术后使用了华法林。出院后,有五名患者(22%)发生出血,其中四名患者采取保守治疗,一名颅内出血患者接受了开颅手术治疗。九名患者(39%)出现了瓣膜相关血栓;两名患者接受了再次手术,26 名患者中的七名接受了阿替普酶治疗。瓣膜相关血栓更常见于瓣膜在环上的患者(P < 0.001)和未使用华法林的患者(P < 0.001)。共有 7 名患者(30%)接受了 MVR 重做,年轻患者(p = 0.029)和环上瓣膜患者(p < 0.001)接受重做的较多(p = 0.029)。整个组群的 5 年存活率为 73%。在瓣环位置组中,5年存活率为88%,而在瓣上位置组中,3个月后存活率为50%,14个月后存活率为25%(P = 0.009)。2 岁以下儿童进行机械瓣膜置换术的并发症发生率很高,包括血栓形成和出血。环上瓣位置似乎是血栓形成和再次手术的风险因素。使用华法林进行抗凝仍然具有挑战性。然而,还需要进一步研究评估替代方案。
{"title":"Mechanical mitral valve endurance in children under 2 years","authors":"Mohamed H. Mashali, Ahmed F. Elmahrouk, Zaheer Ahmad, Osama Abdulrahman, Anas Farag Galleon, Amjad Al-Kouatli, Ahmed A. Jamjoom, Riad Abou Zahr","doi":"10.1186/s43057-024-00131-3","DOIUrl":"https://doi.org/10.1186/s43057-024-00131-3","url":null,"abstract":"The management of mitral valve disease in young children is challenging. Mechanical mitral valves could provide long-term durability; however, the need for anticoagulation increases the risk profile of mechanical valves. We report our experience in mechanical mitral valve replacement (MVR) in children under 2 years of age and evaluate factors affecting the outcomes. The study included all patients younger than 2 years who underwent mechanical MVR between 2000 and 2023. The study outcomes were mitral valve reoperation, bleeding, valve-related thrombosis, and survival. Twenty-three patients were included, with a mean age of 10.2 ± 5.9 months. The mitral valve sizes ranged from 16 to 25 mm, and 6 (26%) were placed in the supra-annular position. Complete heart block occurred in seven patients (30%), and operative mortality occurred in three patients (13%). Postoperative warfarin was used in 17 patients (74%). After discharge, bleeding occurred in five patients (22%), four were managed conservatively, and one had intracranial hemorrhage treated with craniotomy. Nine patients (39%) had valve-related thrombosis; two underwent reoperation, while seven were treated with alteplase in 26 patients. Valve-related thrombosis was more common in patients with supra-annular valves (p < 0.001) and in those who were not on warfarin (p < 0.001). A total of seven patients (30%) underwent redo MVR, and redo was more common in young patients (p = 0.029) and in patients with supra-annular valves (p < 0.001). Survival of the whole cohort was 73% at 5 years. Among the annular position group, 5-year survival was 88%, while among the supra-annular position group, survival was 50% after 3 months and 25% after 14 months (p = 0.009). Mechanical MVR in children younger than 2 years is associated with high complication rates, including thrombosis and bleeding. The supra-annular valve position appears to be a risk factor for thrombosis and reoperation. Anticoagulation with warfarin remains challenging. However, further studies evaluating alternative options are needed. ","PeriodicalId":501458,"journal":{"name":"The Cardiothoracic Surgeon","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141527335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The medical community mourns Professor Dr. Ahmed Hassouna, the renowned editor of The Cardiothoracic Surgeon journal (1957–2024) 医学界悼念《心胸外科医生》杂志著名编辑 Ahmed Hassouna 教授博士(1957-2024 年)
Pub Date : 2024-05-23 DOI: 10.1186/s43057-024-00129-x
Amr Arafat, Elhusseiny Gamil
{"title":"The medical community mourns Professor Dr. Ahmed Hassouna, the renowned editor of The Cardiothoracic Surgeon journal (1957–2024)","authors":"Amr Arafat, Elhusseiny Gamil","doi":"10.1186/s43057-024-00129-x","DOIUrl":"https://doi.org/10.1186/s43057-024-00129-x","url":null,"abstract":"","PeriodicalId":501458,"journal":{"name":"The Cardiothoracic Surgeon","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141102832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A formative mixed methods evaluation of a new Ross program: why context matters 对罗斯新计划的形成性混合方法评估:为什么背景很重要?
Pub Date : 2024-05-20 DOI: 10.1186/s43057-024-00128-y
Kyle S. Bilodeau, Frank F. Yang, Michael Shang, Audrey Mossman, David C. Mauchley, Scott DeRoo, Christopher R. Burke
{"title":"A formative mixed methods evaluation of a new Ross program: why context matters","authors":"Kyle S. Bilodeau, Frank F. Yang, Michael Shang, Audrey Mossman, David C. Mauchley, Scott DeRoo, Christopher R. Burke","doi":"10.1186/s43057-024-00128-y","DOIUrl":"https://doi.org/10.1186/s43057-024-00128-y","url":null,"abstract":"","PeriodicalId":501458,"journal":{"name":"The Cardiothoracic Surgeon","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141121896","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: An alternative surgical approach for isolated pulmonary valve infective endocarditis secondary to restrictive ventricular septal defect: a case report 更正:限制性室间隔缺损继发孤立性肺动脉瓣感染性心内膜炎的另一种手术方法:病例报告
Pub Date : 2024-05-18 DOI: 10.1186/s43057-024-00130-4
Hossameldin Hussein, Ahmed Youssef, Ahmed Mahgoub, Noha Gamal, Amr Farrag, Soha Romeih

Correction: Cardiothorac Surg 32, 4 (2024)

https://doi.org/10.1186/s43057-024-00123-3


Following publication of the original article [1], the authors would like to remove exact dates in the case timeline of events to maintain patient’s confidentiality.

New Case timeline

4 weeks before presentation

• Vaginal delivery, followed by recurrent fever attacks.

On presentation

• Fever and shortness of breath.

Same day of admission

• Transthoracic echocardiography confirmed VSD and showed PV vegetations.

• Blood culture sets withdrawn, and empirical antibiotics started.

3 days after admission

• Antibiotics adjusted according to blood culture and sensitivity.

8 days after admission

• No response to antibiotics with persistent high-grade fever and pulmonary showering.

• Heart team discussion recommended surgical intervention for the PV.

9 days after admission

• PV replacement with Freestyle valve and direct VSD closure with pericardial bledgeted sutures

8 days after surgery

• Step-down to intermediate care in ward

4 weeks after surgery

• Negative blood cultures.

• Completed antibiotic course and discharged.

Follow-up after 1 year

• No symptoms.

• Well-functioning PV Freestyle by echocardiography and CT pulmonary angiography.

The corrections do not affect the overall result or conclusion of the article. The original article has been corrected.

  1. Hussein H, Youssef A, Mahgoub A et al (2024) An alternative surgical approach for isolated pulmonary valve infective endocarditis secondary to restrictive ventricular septal defect: a case report. Cardiothorac Surg 32:4. https://doi.org/10.1186/s43057-024-00123-3

    Article Google Scholar

Download references

Authors and Affiliations

  1. Cardiology Department, Kasr Al-Ainy Medical School, Cairo University, Cairo, Egypt

    Hossameldin Hussein

  2. Adult Cardiology Department, Aswan Heart Centre, Magdi Yacoub Foundation, Aswan, Egypt

    Hossameldin Hussein

  3. Cardiac Surgery Department, Aswan Heart Centre, Magdi Yacoub Foundation, Aswan, Egypt

    Ahmed Youssef & Ahmed Mahgoub

  4. Cardiothoracic Surgery Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt

    Ahmed Youssef

  5. Adult Congenital Heart

更正:Cardiothorac Surg 32, 4 (2024)https://doi.org/10.1186/s43057-024-00123-3Following 原文[1]发表后,作者希望删除病例事件时间表中的确切日期,以便为患者保密。新病例时间表发病前4周--阴道分娩,随后反复发热。发病时--发热和呼吸急促。入院当天--经胸超声心动图证实VSD并显示PV植物样变。入院后 3 天- 根据血培养和敏感性调整抗生素。入院后数天--抗生素治疗无效,持续高烧和肺部淋巴结肿大。入院后9天--用Freestyle瓣膜置换PV,并用心包出血缝合直接关闭VSD术后8天--降级至中级护理病房术后4周--血培养阴性--完成抗生素疗程并出院。1年后随访--无症状--超声心动图和CT肺血管造影显示Freestyle PV功能良好。Hussein H, Youssef A, Mahgoub A et al (2024) 继发于局限性室间隔缺损的孤立性肺动脉瓣感染性心内膜炎的另一种手术方法:病例报告。Cardiothorac Surg 32:4. https://doi.org/10.1186/s43057-024-00123-3Article Google Scholar Download references作者及工作单位埃及开罗开罗大学Kasr Al-Ainy医学院心内科Hossameldin Hussein埃及阿斯旺Magdi Yacoub基金会阿斯旺心脏中心成人心内科Hossameldin Hussein埃及阿斯旺Magdi Yacoub基金会阿斯旺心脏中心心脏外科Ahmed Youssef &;Ahmed Mahgoub埃及亚历山大 亚历山大大学医学院心胸外科 Ahmed Youssef埃及阿斯旺 Magdi Yacoub 基金会阿斯旺心脏中心成人先天性心脏病科Noha Gamal &;Soha RomeihAdult Critical Care Department, Aswan Heart Centre, Magdi Yacoub Foundation, Aswan, EgyptAmr FarragCardiology Department, Faculty of Medicine, Tanta University, Tanta、EgyptSoha RomeihAuthorsHossameldin HusseinView Author publications您也可以在PubMed Google ScholarAhmed YoussefView Author publications您也可以在PubMed Google ScholarAhmed MahgoubView Author publications您也可以在PubMed Google ScholarNohaGamalView 作者发表作品您也可以在 PubMed Google ScholarAmr FarragView 作者发表作品您也可以在 PubMed Google ScholarSoha RomeihView 作者发表作品您也可以在 PubMed Google ScholarCorresponding author给 Hossameldin Hussein 的回信。开放存取 本文采用知识共享署名 4.0 国际许可协议进行许可,该协议允许以任何媒介或格式使用、共享、改编、分发和复制本文,但须注明原作者和出处,提供知识共享许可协议链接,并说明是否进行了修改。本文中的图片或其他第三方材料均包含在文章的知识共享许可协议中,除非在材料的署名栏中另有说明。如果材料未包含在文章的知识共享许可协议中,且您打算使用的材料不符合法律规定或超出许可使用范围,您需要直接从版权所有者处获得许可。如需查看该许可的副本,请访问 http://creativecommons.org/licenses/by/4.0/.Reprints and permissionsCite this articleHussein, H., Youssef, A., Mahgoub, A. et al. Correction:继发于限制性室间隔缺损的孤立性肺动脉瓣感染性心内膜炎的另一种手术方法:病例报告。Cardiothorac Surg 32, 9 (2024). https://doi.org/10.1186/s43057-024-00130-4Download citationPublished: 18 May 2024DOI: https://doi.org/10.1186/s43057-024-00130-4Share this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative
{"title":"Correction: An alternative surgical approach for isolated pulmonary valve infective endocarditis secondary to restrictive ventricular septal defect: a case report","authors":"Hossameldin Hussein, Ahmed Youssef, Ahmed Mahgoub, Noha Gamal, Amr Farrag, Soha Romeih","doi":"10.1186/s43057-024-00130-4","DOIUrl":"https://doi.org/10.1186/s43057-024-00130-4","url":null,"abstract":"<p><b>Correction</b><b>: </b><b>Cardiothorac Surg 32, 4 (2024)</b></p><p><b>https://doi.org/10.1186/s43057-024-00123-3</b></p><br/><p>Following publication of the original article [1], the authors would like to remove exact dates in the case timeline of events to maintain patient’s confidentiality.</p><p><b>New Case timeline</b></p><table><tbody><tr><td><p>4 weeks before presentation</p></td><td><p>• Vaginal delivery, followed by recurrent fever attacks.</p></td></tr><tr><td><p>On presentation</p></td><td><p>• Fever and shortness of breath.</p></td></tr><tr><td><p>Same day of admission</p></td><td><p>• Transthoracic echocardiography confirmed VSD and showed PV vegetations.</p><p>• Blood culture sets withdrawn, and empirical antibiotics started.</p></td></tr><tr><td><p>3 days after admission</p></td><td><p>• Antibiotics adjusted according to blood culture and sensitivity.</p></td></tr><tr><td><p>8 days after admission</p></td><td><p>• No response to antibiotics with persistent high-grade fever and pulmonary showering.</p><p>• Heart team discussion recommended surgical intervention for the PV.</p></td></tr><tr><td><p>9 days after admission</p></td><td><p>• PV replacement with Freestyle valve and direct VSD closure with pericardial bledgeted sutures</p></td></tr><tr><td><p>8 days after surgery</p></td><td><p>• Step-down to intermediate care in ward</p></td></tr><tr><td><p>4 weeks after surgery</p></td><td><p>• Negative blood cultures.</p><p>• Completed antibiotic course and discharged.</p></td></tr><tr><td><p>Follow-up after 1 year</p></td><td><p>• No symptoms.</p><p>• Well-functioning PV Freestyle by echocardiography and CT pulmonary angiography.</p></td></tr></tbody></table><p>The corrections do not affect the overall result or conclusion of the article. The original article has been corrected.</p><ol data-track-component=\"outbound reference\"><li data-counter=\"1.\"><p>Hussein H, Youssef A, Mahgoub A et al (2024) An alternative surgical approach for isolated pulmonary valve infective endocarditis secondary to restrictive ventricular septal defect: a case report. Cardiothorac Surg 32:4. https://doi.org/10.1186/s43057-024-00123-3</p><p>Article Google Scholar </p></li></ol><p>Download references<svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"><use xlink:href=\"#icon-eds-i-download-medium\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"></use></svg></p><h3>Authors and Affiliations</h3><ol><li><p>Cardiology Department, Kasr Al-Ainy Medical School, Cairo University, Cairo, Egypt</p><p>Hossameldin Hussein</p></li><li><p>Adult Cardiology Department, Aswan Heart Centre, Magdi Yacoub Foundation, Aswan, Egypt</p><p>Hossameldin Hussein</p></li><li><p>Cardiac Surgery Department, Aswan Heart Centre, Magdi Yacoub Foundation, Aswan, Egypt</p><p>Ahmed Youssef &amp; Ahmed Mahgoub</p></li><li><p>Cardiothoracic Surgery Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt</p><p>Ahmed Youssef</p></li><li><p>Adult Congenital Heart","PeriodicalId":501458,"journal":{"name":"The Cardiothoracic Surgeon","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141060853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Cardiothoracic Surgeon
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1